1. Market Research
  2. > Biotechnology
  3. > Biopharmaceutical Market Trends
  4. > Levemir Penfill-Drug Insights,2014

Levemir Penfill-Drug Insights,2014

  • June 2014
  • -
  • Delve Insight

DelveInsight’s pharmaceuticals report, “Levemir Penfill - Drug Insights, 2014” provides Levemir Penfill marketed details and API Manufacturers details across the globe along with the location. In addition, it covers sales estimates for the US, detailed clinical assessment of the drug, patent details, route of synthesis, competitive landscape, and analysis of sales performance during the forecast period (2011-2015). The report also includes SWOT analysis for the drug. This report is built using data and information sourced from DelveInsight proprietary databases, primary and secondary research using Company’s corporate website, SEC filings, investor presentations and featured press releases, both from company and industry-specific third party sources, put together with in-house analysis, by DelveInsight team of industry experts.

Data Sources
The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by DelveInsight team of industry experts.

Secondary sources information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Magazines, Trade associations, Books, Industry Portals, Industry Associations and access to available databases.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated drug.

Scope
- A review of the Levemir Penfill based on information derived from company and industry-specific sources
- Coverage of the Marketed data of the Levemir Penfill on the basis of MOA, target, dosage, route of administration, molecule type, strength, Chemical type and ATC Classification
- Coverage of the United States Drug Master File (US DMF), Active Substance Master File/EU DMF and API Manufactures in China & India for Schizophrenia drugs with location details
- Patent Expiry Timeline and Exclusivity Details
- Route of Synthesis of the API
- Global Forecasted Sales Figure from 2011-2015
- Qualitative and quantitative assessment of market space
- SWOT Analysis

Reasons to buy
- Evaluate the marketing status and exclusivity details of Levemir Penfill to exploit opportunities for generic drug development opportunities.
- Design effective counter-strategies to gain competitive advantage by identifying the key patent expiry details and exclusivity with respect to Levemir Penfill.
- API intelligence over Levemir Penfill and gaining primary intelligence over Active Ingredients manufacturers across the globe.
- Understanding the chemical route of synthesis of Levemir Penfill.
- Uncovering opportunities in the rapidly growing the US market
- Stay ahead of competition by understanding the changing competitive landscape
- Effectively plan your M&A and partnership strategies by identifying drugs with the most promising sales potential
- Make more informed business decisions from insightful and in-depth analysis of the drug’s performance
- Obtain sales forecast for currently marketed drug for 2011-2015

Table Of Contents

Levemir Penfill-Drug Insights,2014
- Drug Overview
- Global Sales Assessment
- Product Description
- Mechanism of Action
- Pharmacodynamic Properties
- Pharmacokinetic Properties
- Marketed Details for the United States
- Marketed Details for the Europe
- Patent Information
- Patent and Exclusivity Expiry Assessment United States (US)
- Patent Numbers and Expiry Details
- Patent Details
- Route of Synthesis
- Global API Manufacturers Assessment
- The United States Drug Master File (US DMF)
- The Europe Drug Master File (EUDMF)/Active Substance Master File (ASMF)
- The Active Pharmaceutical Ingredient (API) Manufacturers in the ASIA Region
- The Active Pharmaceutical Ingredient (API) Manufacturers by the United States Drug Master (DMF) File Status
- The Active Pharmaceutical Ingredient (API) Manufacturers by Region
- The Active Pharmaceutical Ingredient (API) Manufacturers by Location/Countries
- Generic Players
- The Pipeline Coverage
- Clinical Trials Information
- Clinical Trials by Zone
- Company Profile
- Summary
- Company Financials
- SWOT Analysis
- References
- Appendix
- Methodology
- About DelveInsight
- Contact Us
- Disclaimer


List of Tables
- Levemir Penfill, Market, Global Sales (in USD), 2014
- Levemir Penfill, Description
- Levemir Penfill, Marketed Details the United States (US)
- Levemir Penfill, Marketed Details the Europe (EU)
- Levemir Penfill, Patent/Exclusivity Expiry (Year), 2014
- Levemir Penfill, Patent Number Specific Patent Expiry (Year), 2014
- Levemir Penfill, Patent Details
- Levemir Penfill, Route of Synthesis
- Levemir Penfill, the United States Drug Master File (US DMF), 2014
- Levemir Penfill, the Europe Drug Master File (EUDMF)/Active Substance Master File (ASMF), 2014
- Levemir Penfill, the API Manufacturers, China, 2014
- Levemir Penfill, the API Manufacturers, India, 2014
- Levemir Penfill, the API Manufacturers by the US DMF Status, 2014
- Levemir Penfill, the API Manufacturers by Region, 2014
- Levemir Penfill, the API Manufacturers by Location/Countries, 2014
- Levemir Penfill, Generic Players, 2014
- Levemir Penfill, Pipeline Drug Details, 2014
- Levemir Penfill, Clinical Trials, 2014
- Levemir Penfill, Clinical Trials by Zone, 2014
- Company Overview, 2014
- Levemir Penfill, SWOT Analysis, 2014
- Phase III Pipeline Therapeutics, 2014

List of Figures
- Levemir Penfill, Market, Global Sales (in million USD), 2014
- Levemir Penfill, Global Sales % Change, 2014
- Levemir Penfill, Patent/Exclusivity Expiry (Year), 2014
- Levemir Penfill, Patent Number Specific Patent Expiry (Year), 2014
- Levemir Penfill, Route of synthesis
- Levemir Penfill, the API Manufacturers by the US DMF Status (%), 2014
- Levemir Penfill, the API Manufacturers by Region, 2014
- Levemir Penfill, the API Manufacturers by Location/Countries, 2014
- Levemir Penfill, Generic Players, 2014
- Levemir Penfill, Clinical Trials by Zone (%), 2014

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Global Markets for Protein Labeling

Global Markets for Protein Labeling

  • $ 6650
  • Industry report
  • February 2017
  • by BCC Research

Use this report to: - Identify key market dynamics and the factors impacting the global protein-labeling market and its subsegments. - Gain insight into global protein-labeling market and its market segments, ...

Global Laboratory Products Purchasing Trends, 2016–2017

Global Laboratory Products Purchasing Trends, 2016–2017

  • $ 6000
  • Industry report
  • December 2016
  • by Frost & Sullivan

An End-user Perspective on the Purchasing Process, Product Budgets, and Top Companies for Laboratory Products Readers of Lab Manager Magazine were invited to participate in an online survey in July 2016. ...

Biosimilars Market by Product, Manufacturing, Application - Global Forecast to 2021

Biosimilars Market by Product, Manufacturing, Application - Global Forecast to 2021

  • $ 5650
  • Industry report
  • January 2017
  • by MarketsandMarkets

Biosimilars Market by Product (Recombinant Non-glycosylated Proteins (Insulin, rHGH, Interferon), glycosylated (mAb, EPO), Peptides (Glucagon, Calcitonin)), Manufacturing (In-House, CM0) & Application ...


ref:plp2014

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.